NIOX NIOX Group Plc

0.7822USD59.40 GBp · LSE-2.62%Mkt Cap: 317.01M USDP/E: 29.70

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and poi…

Institutional holders2 on file

Key Statistics

Company
Market Cap317.01M USD
Enterprise Value306.67M USD
Revenue (TTM)62.55M USD
Gross Profit44.38M USD
Net Income (TTM)9.22M USD
Revenue/Share0.15 USD
Last Price0.7822 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees97
CountryGB
SectorHealthcare
IndustryMedical Devices
ISINGB00BJVD3B28
Valuation
P/E (Trailing)29.70
P/E (Forward)16.86
PEG—
EV/EBITDA16.40
EV/Revenue4.90
P/S5.07
P/B3.76
EPS (TTM)0.03 USD
EPS (Forward)0.05 USD
52W Range
0.709021% of range1.053
52W High1.053 USD
52W Low0.7090 USD
Profitability
Gross Margin69.20%
Oper. Margin21.89%
EBITDA Margin29.90%
Profit Margin14.37%
ROE10.36%
ROA9.19%
ROIC13.73%
ROCE15.71%
Growth
Revenue Growth-4.80%
Earnings Growth-0.70%
Cash Flow & Leverage
Operating CF20.28M USD
CapEx (TTM)1.98M USD
FCF Margin17.26%
FCF Yield3.41%
Net Debt-21.20M USD
Net Debt/EBITDA-1.13
Net Debt/FCF-1.96
Balance Sheet
Debt/Equity0.01
Current Ratio4.60
Quick Ratio3.32
Book Value/Sh0.21 USD
Cash/Share0.05 USD
Dividends
Fwd Div Rate0.0003 USD
Trail. Div Rate0.0002 USD
Div. Yield2.54%
5Y Avg Yield—
Payout Ratio95.09%
Ex-Div DateMay 21, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.085 USD
Upside (mean)+38.7%
Target Range1.014 USD – 1.132 USD
1.014+38.7% to mean1.132
# Analysts5
Ownership
Shares Out.405.27M
Float329.10M
Insiders21.65%
Institutions68.25%
Technical
SMA 500.8738 (-10.5%)
SMA 2000.8253 (-5.2%)
Beta-0.09
S&P 52W Chg12.00%
Avg Vol (30d)1.08M
Avg Vol (10d)777.02K
Technical Indicators
RSI (14)32.8
MACD-1.6766
MACD Signal-1.1275
MACD Hist.-0.5490
BB Upper0.9286 USD
BB Middle0.8525 USD
BB Lower0.7764 USD
BB Width17.85%
ATR (14)0.0453 USD
Vol Ratio (20d)0.60x

About NIOX Group (LON: NIOX)

›

NIOX Group (LON: NIOX) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 97 employees.

The shares were at 59.40 GBp on 19 November 2026, down 15.6% over 52 weeks. Its 52-week range is 53.84 GBp to 80.00 GBp: the price is 25.7% below the high and 10.3% above the low.

At a market capitalisation of 240.73M GBP, it trades at 29.7 times trailing earnings and 16.9 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 16% for NIOX. It pays a dividend yielding 2.54% (it pays out 95% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

NIOX Group reports return on equity of 10.4%, an operating margin of 21.9% and revenue down 4.8% year over year.

It holds more cash than debt, a net cash position of 16.10M GBP. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 5 analysts cover the stock; their mean price target of 82.40 GBp is 38.7% above the current price. The next earnings report is expected on 23 March 2027.